Can you combine Paxlovid with other COVID-19 drugs? FDA says no, for some

Can you combine Paxlovid with other COVID-19 drugs? FDA says no, for some

Taking Pfizer’s blockbuster COVID-19 pills, Paxlovid, at the same time as a rival’s treatment for the virus might be safe and more effective than either drug alone, federal scientists have found.  The combination might also offer a solution to so-called “rebound” cases, when patients see a return of symptoms after finishing off a course of … Read more

Latest COVID booster shots will be released before human testing is complete

Latest COVID booster shots will be released before human testing is complete

The Food and Drug Administration is expected to approve new COVID-19 booster shots this week — before the vaccines are tested on humans, according to a new report by the Wall Street Journal. The new boosters are similar to the COVID vaccines currently available in the US with minor modifications that protect recipients from the … Read more

Artificial sweeteners could cause diabetes, shocking new research says

Artificial sweeteners could cause diabetes, shocking new research says

Real sugar can quickly add calories, but artificial sugar can lead to diabetes. Scientists are now warning that some artificial sweeteners may alter the body’s microbes in a way that alters blood sugar levels, according to new data published in the journal “Cell” and reported by the Southwest News Service. is in accordance. Sugar substitutes … Read more

Study finds adults with blood cancer respond to booster dose of COVID-19 vaccination rather than first dose – Times of India

Study finds adults with blood cancer respond to booster dose of COVID-19 vaccination rather than first dose – Times of India

WASHINGTON: Less than half of patients with hematologic malignancies developed detectable antibodies after initial COVID-19 vaccination, but 56 percent of “non-responders” developed antibodies after receiving a booster dose, according to a recent study. . The research findings were published in the journal Cancer. for study, Thomas OlillaBrown University MD, and colleagues retrospectively analyzed antibody responses … Read more